InVivoMAb anti-mouse CD8 (Lyt 2.1)
|116-13.1 (HB129)||BE0118||InVivoMab Antibodies|
References provided by Bioz:
Powered by Bioz
About InVivoMAb anti-mouse CD8 (Lyt 2.1)
The 116-13.1 monoclonal antibody reacts with mouse CD8 also known as Lyt-2. The CD8 antigen is a transmembrane glycoprotein that acts as a co-receptor for the T cell receptor (TCR). Like the TCR CD8 binds to class I MHC molecules displayed by antigen presenting cells (APC). CD8 is primarily expressed on the surface of cytotoxic T cells but can also be found on thymocytes natural killer cells and some dendritic cell subsets. CD8 most commonly exists as a heterodimer composed of one CD8α and one CD8β chain however it can also exist as a homodimer composed of two CD8αchains. Both the CD8α and CD8β chains share significant homology to immunoglobulin variable light chains. The molecular weight of each CD8 chain is approximately 34 kDa. The 116-13.1 antibody exhibits depleting activity when used in vivo .
InVivoMAb anti-mouse CD8 (Lyt 2.1) Specifications
Mouse IgG2a, κ
|Recommended Isotype Control(s)||InVivoMAb mouse IgG2a isotype control, unknown specificity(BE0085)|
|Recommended InVivoPure Dilution Buffer||InVivoPure pH 7.0 Dilution Buffer(IP0070)|
CE mouse spleen cells and thymocytes
0.2 μM filtered
Purified from tissue culture supernatant in an animal free facility
The antibody solution should be stored undiluted at 4°C, and protected from prolonged exposure to light. Do not freeze.